EVIO, Inc. (OTCQB: EVIO), a leading provider of cannabis testing and scientific research for the regulated cannabis industry, this morning announced that it has completed its previously detailed acquisition of Oregon-based MRX Labs, LLC, an award-winning testing lab. Per the update, EVIO has acquired 100 percent of the assets of MRX Labs, including equipment, real estate, customer lists, customer contracts, rental agreements and equipment leases. EVIO Labs Portland intends to relocate its personnel and license to the former MRX Labs Tigard location, and the new lab will operate as EVIO Labs Portland. “We are happy to have completed this transaction and add MRX Labs to our portfolio,” William Waldrop, CEO of EVIO, stated in the news release. “MRX Labs is well known for outstanding client care and service, and we want their clients to know that we are extremely focused on making the transition as smooth and seamless as possible.”
To view the full press release, visit http://cnw.fm/5fbdG
About EVIO, Inc.
EVIO Inc. is a leading provider of cannabis testing and scientific research for the regulated cannabis industry. The company’s EVIO Labs division operates coast-to-coast providing state-mandated ancillary services to ensure the safety and quality of the nation’s cannabis supply. The company’s EVIO Biosciences Division is dedicated to the scientific, medical, and psychosocial exploration of clinical cannabis, cannabinoids, and the endocannabinoid system. For more information, visit the company’s website at www.EvioLabs.com
More from CannabisNewsBreaks
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
For more information please visit https://www.cannabisnewswire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
